December 20, 2014 3:03 AM ET

Healthcare Providers and Services

Company Overview of Dana-Farber Cancer Institute, Inc.

Company Overview

Dana-Farber Cancer Institute, Inc. provides cancer treatment and research services for adults and children in the United States. It offers adult treatment and care services for blood, breast, cutaneous/skin, gastrointestinal, genitourinary, gynecological, head and neck, hematology, melanoma, neuro-oncology, sarcoma, and thoracic cancer; and cancer genetics and prevention services. The company also provides treatment and care for children with cancer, such as blood diseases, bone and soft tissue tumors, brain tumors, histiocytosis, Hodgkin lymphoma, kidney tumors, leukemia, neuroblastoma, non-Hodgkin lymphoma, and rare tumors program. In addition, it offers training in cancer treatment and re...

450 Brookline Avenue

Boston, MA 02215-5450

United States

Founded in 1947

Phone:

617-632-3000

Fax:

617-632-3057

Key Executives for Dana-Farber Cancer Institute, Inc.

Chief Executive Officer and President
Top Key
Age: 49
Chief Financial Officer and Assistant Treasurer
Chief Operating Officer and Executive Vice President
Age: 63
Senior Vice President and General Counsel
Compensation as of Fiscal Year 2014.

Dana-Farber Cancer Institute, Inc. Key Developments

Dana-Farber Cancer Institute and Astellas Announce Research Collaboration

Dana-Farber Cancer Institute (Dana-Farber) and Astellas Pharma Inc. announced a three-year collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer. K-Ras is the most commonly mutated oncogene in human cancers, with about 30% of all cancers harbouring activating rasmutations. Furthermore, cancers with a high prevalence of K-Ras mutations, such as lung cancer and pancreatic cancer, are difficult to treat and clinical outcomes are poor even with aggressive medical interventions. Despite more than 20 years of research by industry and academia, K-Ras has proven highly difficult to target and no effective therapy currently exists.

Dana-Farber Cancer Institute, Inc. Presents at Citi's 9th Annual Biotech Conference, Sep-03-2014 04:00 PM

Dana-Farber Cancer Institute, Inc. Presents at Citi's 9th Annual Biotech Conference, Sep-03-2014 04:00 PM. Venue: The Mandarin Oriental Boston, 776 Boylston Street, Boston, MA 02119, United States. Speakers: Charles Fuchs, Director of the Center for Gastrointestinal Cancer.

Dana-Farber Cancer Institute, Inc. Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Oct-01-2014 11:15 AM

Dana-Farber Cancer Institute, Inc. Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Oct-01-2014 11:15 AM. Venue: Congress Center Basel, MCH Messe Schweiz (Basel) AG, CH-4005 Basel, Switzerland. Speakers: Prem Das, Chief Research Business Development Officer and heads DFCI's Office of Research and Technology Ventures.

Similar Private Companies By Industry

Company Name Region
Venice HMA, LLC United States
Mission Hospital Laguna Beach United States
MyHealthFunds, Inc. United States
Quantitative Imaging of Iowa Inc. United States
Fort Smith HMA, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Dana-Farber Cancer Institute, Inc., please visit www.dana-farber.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.